USP <382> - How to generate regulatory-ready data for drug development
USP <382> changes how elastomer components are qualified - shifting from component‑level testing to system‑level suitability of the final packaging configuration. This raises new expectations for functional evidence and regulatory submissions.
In this webinar, SCHOTT Pharma experts explain the regulatory implications, highlight critical functional tests, and show how real‑world data helps de‑risk decisions from container selection to filing. Learn how early alignment with SCHOTT Pharma can reduce development loops and increase confidence throughout the regulatory process.
In this webinar, SCHOTT Pharma experts explain the regulatory implications, highlight critical functional tests, and show how real‑world data helps de‑risk decisions from container selection to filing. Learn how early alignment with SCHOTT Pharma can reduce development loops and increase confidence throughout the regulatory process.
